MYX mayne pharma group limited

E4 is an interesting propositionit may end up being betterbut...

  1. 154 Posts.
    lightbulb Created with Sketch. 26
    E4 is an interesting proposition
    it may end up being better
    but will it replace the incumbents?
    kind of like lozanoc/itragerm/tolsura vs sporanox
    Time to market
    and to equal the incumbent
    can be difficult even for better products
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.08
Change
0.010(0.20%)
Mkt cap ! $412.7M
Open High Low Value Volume
$5.13 $5.15 $5.08 $445.2K 87.01K

Buyers (Bids)

No. Vol. Price($)
1 810 $5.08
 

Sellers (Offers)

Price($) Vol. No.
$5.15 2033 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.